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Influence on Body Fat of Linoleic Acid Isomers
Kim Hargrave
Kristin Nollette
Merlyn Nielsen
Jess Miner1
A conjugated isomer of linoleic
acid, C18:2 ∆10,12, caused body
fat depletion when fed to mice. The
effect was greater in mice fed essen-
tial fatty acid (linoleic/linolenic)
deficient diets.
Summary
In two studies mice were fed diets
containing either a mixture of, or
individual conjugated linoleic acid
(CLA) isomers in the presence or
absence of essential fatty acids. Mice
fed the C18:2 ∆10,12 CLA isomer
lost as much body fat as those fed a
mixture of isomers. This effect was not
caused by the C18:2 ∆9,11 isomer
(predominant in beef) or by restricted
feed intake. The loss was much greater
in mice consuming an essential fatty
acid deficient diet versus a control
diet. This supports our hypothesis
that for CLA to deplete body fat, it
must first be metabolized in a manner
similar to linoleic acid. Furthermore,
we suggest that the loss of body fat
may be mediated by metabolism of
CLA to an isomer of arachidonic acid.
Introduction
Conjugated linoleic acid (CLA) is a
group of isomers of linoleic acid (C18:2
∆9,12), some of which are produced
naturally and deposited in the fat of
ruminant animals. CLA consumption
has health benefits regarding cancer,
cardiovascular disease and body com-
position. The predominant naturally
occurring isomer is C18:2 ∆9,11 (CLA
9/11), while commercially synthesized
CLA products usually contain relatively
equal amounts of C18:2 ∆10,12 (CLA
10/12) and CLA 9/11 as well as smaller
quantities of other isomers. The diverse
benefits of CLA may depend on differ-
ent isomers. Therefore our first objec-
tive was to determine which isomer(s)
are responsible for the loss of body fat
in mice.
Arachidonic acid (C20:4 ∆5,8,11,14)
is synthesized in animals from dietary
linoleic acid. Similarly, CLA 10/12 can
be metabolized to C20:4 ∆5,8,12,14.
This product of CLA metabolism could
antagonize the normal production of
prostaglandins from arachidonic acid
and therefore, mice fed a diet deficient
in linoleic acid, and thus arachidonic
acid, may be especially sensitive to the
antiobesity effect of dietary CLA. Our
second objective was to compare the
effect of CLA in dietary essential fatty
acid-adequate and -deficient diets.
Procedure
Experiment 1
Seventy-two mixed sex mice were
allotted to one of five rations (each 7%
fat) for five days:
Control purified diet with 7%
soy oil
Pair-Fed control diet at intake of
CLA Mix
CLA Mix 2% CLA Mix and 5%
soy oil
CLA 9/11 0.82% CLA 9/11 iso-
mer and 6.18% soy oil
CLA 10/12 0.88% CLA 10/12 iso-
mer and 6.12% soy oil
Feed intake and body weight were
measured daily. After five days the mice
were killed and retroperitoneal (RP) fat
pads were removed and weighed. Body
fat was determined on carcasses by ether
extraction.
Experiment 2
Eighty newly weaned male mice were
fed either a control diet (7% soy oil) or
an essential fatty acid deficient
(EFAD) diet (7% coconut oil) for 6
weeks. Henceforth, half of each group
of mice was supplemented with 0.5%
CLA, replacing either soy or coconut
oil, for two weeks. Then the mice were
killed. RP fat pads, epidymal fat pads,
and livers were removed and weighed.
Carcass fat was determined by ether
extraction.
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Figure 1. Effect of CLA Mix or individual isomers on feed intake (Experiment 1). *CLA 10/12,
CLA Mix, and Pair-Fed differ from Control (P < 0.001).
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Experiment 2
Supplementation of CLA reduced
(P < 0.05) both feed intake and body
weight in the final two weeks of the
study. CLA reduced (P < 0.001) RP
(49%) and epidymal (19%) fat pad
weights when added to the control diet.
Furthermore, CLA reduced total body
fat by 27% (Figure 4). The EFAD diet
alone had no effect on feed intake, body
weight, or body fat. However, when
CLA was fed to mice deficient in essen-
tial fatty acids, its effects were greatly
amplified (P < 0.0001); a 73% reduction
in RP, 57% in epidymal, and 66% in total
body fat (Figure 4).
In conclusion, CLA 10/12 is respon-
sible for the loss of body fat observed
when mice are fed a mixture of CLA
isomers. This loss of body fat may be
mediated through metabolism of CLA
to an isomer of arachidonic acid. Arachi-
donic acid is a precursor to the series
2 prostaglandins, which have a multi-
tude of actions in the body. Therefore,
inhibition of the conversion of arachi-
donic acid to prostaglandin, or the pro-
duction of prostaglandin-like mole-
cules from CLA could explain the varied
benefits of CLA. Essential fatty acids
(linoleic and linolenic) partially protect
against the full effect of CLA, possibly
via competition for a common metabolic
path.
Although ruminant-derived food
products contain mainly the CLA 9/11
isomer, which does not appear to have
any antiobesity effect, it is known that
the CLA in beef and milk provides other
health benefits such as mitigation of
several cancers. CLA 9/11 can be
metabolized similarly to CLA 10/12,
forming a C20:4 ∆5,8,11,13 isomer of
arachidonic acid. Therefore the health
benefits of CLA, other than loss of
body fat, may also be acting through
this pathway.
1Kim Hargrave, graduate student; Kristin
Nollette, undergraduate student; Merlyn Nielsen,
professor, Animal Science, Lincoln; Jess
Miner, assistant professor, Animal Science,
Lincoln.
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Figure 2. Effect of CLA Mix or individual isomers on BW (Experiment 1). No effect on
BW was detected.
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Figure 3. Effect of CLA Mix or individual isomers on body fat (Experiment 1). abcMeans
with different superscripts differ (P < 0.05).
Figure 4. Effect of essential fatty acid deficiency (EFAD) and CLA supplementation on body
fat (Experiment 2). abcMeans with different superscripts differ (P < 0.0001).
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Results
Experiment 1
Feed intake was reduced (P < 0.001)
in mice fed CLA Mix and CLA 10/12 as
well as the Pair-Fed mice, starting on
day 2 (Figure 1). However body weight
was not affected by diet in this short
period (Figure 2). After 5 days of CLA
supplementation there was a 20% loss
(P < 0.05) of body fat in mice fed the
CLA Mix and CLA 10/12 isomer com-
pared to Control mice (Figure 3).
